New York State Attorney General, Letitia James, speaks during a news conference, to announce criminal justice reform in New York City, U.S., May 21, 2021. Brendan McDermid | Reuters New York Attorney General Letitia James announced on Saturday that Johnson & Johnson has agreed to end the manufacture and sale of opioids nationwide in a $… Read More »
According to the most recent Pregnancy Risk Assessment Monitoring System (PRAMS) survey conducted in 2019, 6.6% of the respondents reported prescription opioid use during pregnancy. Use of prescription opioids was more common in certain groups. Prescription opioid use was the highest (10%) in women 19 years and under. Among women who smoked cigarettes during pregnancy,… Read More »
TUESDAY, Feb. 25, 2020 — People treated for an opioid addiction stand a much better chance of breaking their dependency if they take opioid-blocking medications, a new study finds. In fact, addicts who took methadone or buprenorphine had an 80% lower risk of dying from an overdose than those in treatment who are not using… Read More »
“I feel like a caged animal” — My patient offered me this lens through which to view his life seeped in chronic pain. For him, pain dictated his entire sense of being — it was something that simply could not be distilled down to a single value on a 10-point scale. The cage represented the… Read More »
The State of Maryland is getting new software to collect information about controlled substances dispensed in the state to facilitate better data sharing. The RxGov prescription drug monitoring platform, from NIC, provides near real-time data that will integrate with the Chesapeake Regional Information System for our Patients (CRISP), the state health information exchange. Data also… Read More »